This inventor holds 1 USPTO granted patent. Top assignee: Fox Biosystems Nv. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Karel Knez: Innovator in DNA Amplification Technology
Introduction
Karel Knez is a notable inventor based in Aalst, Belgium. He has made significant contributions to the field of nucleic acid quantification and discrimination. His innovative work has led to the development of a patented method that enhances the detection of DNA.
Latest Patents
Karel Knez holds a patent for a method and kits for monitoring DNA amplification. This patent focuses on using surface plasmon resonance (SPR) for nucleic acid quantification. The method significantly improves the detection limit and allows for multiplex discrimination assays by utilizing the melting properties of target DNA alongside standard PCR reactions. By employing heating and cooling cycles of the polymerase chain reaction (PCR) or Ligation chain reaction (LCR), the DNA is melted and hybridized onto the SPR sensor surface with a nanoparticle label. This innovative approach enables the monitoring of both the quantity and type of target DNA during each cycle of amplification. Karel Knez has 1 patent to his name.
Career Highlights
Karel Knez is associated with Fox Biosystems NV, where he continues to advance his research in DNA amplification technologies. His work has positioned him as a key figure in the biotechnology sector, particularly in the development of methods that enhance DNA detection capabilities.
Collaborations
Karel collaborates with esteemed colleagues such as Jeroen Lammertyn and Filip Delport. Their combined expertise contributes to the innovative projects at Fox Biosystems NV.
Conclusion
Karel Knez is a pioneering inventor whose work in DNA amplification technology has the potential to revolutionize nucleic acid quantification. His contributions are vital to advancements in biotechnology and molecular diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile